vs

Side-by-side financial comparison of REV Group, Inc. (REVG) and Revvity (RVTY). Click either name above to swap in a different company.

Revvity is the larger business by last-quarter revenue ($772.1M vs $664.4M, roughly 1.2× REV Group, Inc.). Revvity runs the higher net margin — 12.7% vs 4.3%, a 8.4% gap on every dollar of revenue. On growth, REV Group, Inc. posted the faster year-over-year revenue change (11.1% vs 5.9%). Revvity produced more free cash flow last quarter ($161.8M vs $53.7M). Over the past eight quarters, Revvity's revenue compounded faster (9.0% CAGR vs 6.5%).

Rev is an American speech-to-text company that provides closed captioning, subtitles, and transcription services. The company, based in San Francisco and Austin, was founded in 2010. PC Magazine named the service an "Editor's Choice" in 2018, and ranked it as the best transcription service of 2019.

Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines.

REVG vs RVTY — Head-to-Head

Bigger by revenue
RVTY
RVTY
1.2× larger
RVTY
$772.1M
$664.4M
REVG
Growing faster (revenue YoY)
REVG
REVG
+5.3% gap
REVG
11.1%
5.9%
RVTY
Higher net margin
RVTY
RVTY
8.4% more per $
RVTY
12.7%
4.3%
REVG
More free cash flow
RVTY
RVTY
$108.1M more FCF
RVTY
$161.8M
$53.7M
REVG
Faster 2-yr revenue CAGR
RVTY
RVTY
Annualised
RVTY
9.0%
6.5%
REVG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
REVG
REVG
RVTY
RVTY
Revenue
$664.4M
$772.1M
Net Profit
$28.9M
$98.4M
Gross Margin
15.4%
Operating Margin
7.1%
14.5%
Net Margin
4.3%
12.7%
Revenue YoY
11.1%
5.9%
Net Profit YoY
-30.7%
3.9%
EPS (diluted)
$0.57
$0.86

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
REVG
REVG
RVTY
RVTY
Q4 25
$664.4M
$772.1M
Q3 25
$644.9M
$698.9M
Q2 25
$629.1M
$720.3M
Q1 25
$525.1M
$664.8M
Q4 24
$597.9M
$729.4M
Q3 24
$579.4M
$684.0M
Q2 24
$616.9M
$691.7M
Q1 24
$586.0M
$649.9M
Net Profit
REVG
REVG
RVTY
RVTY
Q4 25
$28.9M
$98.4M
Q3 25
$29.1M
$46.7M
Q2 25
$19.0M
$53.9M
Q1 25
$18.2M
$42.2M
Q4 24
$41.7M
$94.6M
Q3 24
$18.0M
$94.4M
Q2 24
$15.2M
$55.4M
Q1 24
$182.7M
$26.0M
Gross Margin
REVG
REVG
RVTY
RVTY
Q4 25
15.4%
Q3 25
15.8%
53.6%
Q2 25
15.2%
54.5%
Q1 25
13.3%
56.5%
Q4 24
13.2%
Q3 24
13.5%
56.3%
Q2 24
12.5%
55.7%
Q1 24
10.7%
54.6%
Operating Margin
REVG
REVG
RVTY
RVTY
Q4 25
7.1%
14.5%
Q3 25
8.8%
11.7%
Q2 25
7.9%
12.6%
Q1 25
5.3%
10.9%
Q4 24
5.8%
16.3%
Q3 24
4.9%
14.3%
Q2 24
3.7%
12.4%
Q1 24
-1.1%
6.8%
Net Margin
REVG
REVG
RVTY
RVTY
Q4 25
4.3%
12.7%
Q3 25
4.5%
6.7%
Q2 25
3.0%
7.5%
Q1 25
3.5%
6.4%
Q4 24
7.0%
13.0%
Q3 24
3.1%
13.8%
Q2 24
2.5%
8.0%
Q1 24
31.2%
4.0%
EPS (diluted)
REVG
REVG
RVTY
RVTY
Q4 25
$0.57
$0.86
Q3 25
$0.59
$0.40
Q2 25
$0.38
$0.46
Q1 25
$0.35
$0.35
Q4 24
$1.03
$0.77
Q3 24
$0.35
$0.77
Q2 24
$0.28
$0.45
Q1 24
$3.06
$0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
REVG
REVG
RVTY
RVTY
Cash + ST InvestmentsLiquidity on hand
$34.7M
$919.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$416.3M
$7.3B
Total Assets
$1.2B
$12.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
REVG
REVG
RVTY
RVTY
Q4 25
$34.7M
$919.9M
Q3 25
$36.0M
$931.4M
Q2 25
$28.8M
$991.8M
Q1 25
$31.6M
$1.1B
Q4 24
$24.6M
$1.2B
Q3 24
$50.5M
$1.2B
Q2 24
$38.2M
$2.0B
Q1 24
$87.9M
$1.7B
Stockholders' Equity
REVG
REVG
RVTY
RVTY
Q4 25
$416.3M
$7.3B
Q3 25
$387.3M
$7.4B
Q2 25
$357.8M
$7.6B
Q1 25
$428.8M
$7.6B
Q4 24
$435.1M
$7.7B
Q3 24
$394.6M
$7.9B
Q2 24
$379.7M
$7.9B
Q1 24
$496.1M
$7.8B
Total Assets
REVG
REVG
RVTY
RVTY
Q4 25
$1.2B
$12.2B
Q3 25
$1.2B
$12.1B
Q2 25
$1.2B
$12.4B
Q1 25
$1.2B
$12.4B
Q4 24
$1.2B
$12.4B
Q3 24
$1.3B
$12.8B
Q2 24
$1.3B
$13.4B
Q1 24
$1.4B
$13.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
REVG
REVG
RVTY
RVTY
Operating Cash FlowLast quarter
$76.9M
$182.0M
Free Cash FlowOCF − Capex
$53.7M
$161.8M
FCF MarginFCF / Revenue
8.1%
21.0%
Capex IntensityCapex / Revenue
3.5%
2.6%
Cash ConversionOCF / Net Profit
2.66×
1.85×
TTM Free Cash FlowTrailing 4 quarters
$190.0M
$509.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
REVG
REVG
RVTY
RVTY
Q4 25
$76.9M
$182.0M
Q3 25
$60.3M
$138.5M
Q2 25
$117.0M
$134.3M
Q1 25
$-13.1M
$128.2M
Q4 24
$68.6M
$174.2M
Q3 24
$14.4M
$147.9M
Q2 24
$40.1M
$158.6M
Q1 24
$-69.7M
$147.6M
Free Cash Flow
REVG
REVG
RVTY
RVTY
Q4 25
$53.7M
$161.8M
Q3 25
$48.7M
$120.0M
Q2 25
$105.6M
$115.5M
Q1 25
$-18.0M
$112.2M
Q4 24
$63.3M
$149.8M
Q3 24
$8.5M
$125.6M
Q2 24
$34.2M
$136.6M
Q1 24
$-80.2M
$129.7M
FCF Margin
REVG
REVG
RVTY
RVTY
Q4 25
8.1%
21.0%
Q3 25
7.6%
17.2%
Q2 25
16.8%
16.0%
Q1 25
-3.4%
16.9%
Q4 24
10.6%
20.5%
Q3 24
1.5%
18.4%
Q2 24
5.5%
19.7%
Q1 24
-13.7%
20.0%
Capex Intensity
REVG
REVG
RVTY
RVTY
Q4 25
3.5%
2.6%
Q3 25
1.8%
2.6%
Q2 25
1.8%
2.6%
Q1 25
0.9%
2.4%
Q4 24
0.9%
3.4%
Q3 24
1.0%
3.3%
Q2 24
1.0%
3.2%
Q1 24
1.8%
2.7%
Cash Conversion
REVG
REVG
RVTY
RVTY
Q4 25
2.66×
1.85×
Q3 25
2.07×
2.97×
Q2 25
6.16×
2.49×
Q1 25
-0.72×
3.03×
Q4 24
1.65×
1.84×
Q3 24
0.80×
1.57×
Q2 24
2.64×
2.87×
Q1 24
-0.38×
5.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

REVG
REVG

Specialty Vehicles$507.4M76%
Recreational Vehicles$157.2M24%

RVTY
RVTY

Immunodiagnostics$240.8M31%
Life Sciences$191.4M25%
Reproductive Health$149.3M19%
Segment Operating Income$132.0M17%
Software$62.3M8%

Related Comparisons